首页> 外文期刊>Anaerobe >Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates
【24h】

Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates

机译:EUCAST纸片扩散方法的开发,用于脆弱类拟杆菌群分离物的药敏试验

获取原文
获取原文并翻译 | 示例
           

摘要

With the emergence of antibiotic resistance among Bacteroides fragilis group isolates the need of susceptibility testing in routine laboratories is increasing. The aims of the present study were to evaluate the disk diffusion method for susceptibility testing in case of different clinical isolates of Bacteroides spp by comparing zone diameter results with MICs obtained earlier during an Europe-wide antibiotic susceptibility surveillance, and to propose zone diameter breakpoints, which correlate for the EUCAST MIC breakpoints. We tested 381 clinical isolates of the B. fragilis group to amoxicillin/clavulanic acid, cefoxitin, clindamycin, imipenem, metronidazole, moxifloxacin, piperacillin/tazobactam, tigecycline by agar dilution method previously. The inhibition zones of the same antibiotics including meropenem disc were determined by the disc diffusion on Brucella blood agar supplemented with haemin and vitamin K1. Plates were incubated at 37 degrees C in an anaerobic atmosphere for 24 h. The zone diameters were read at 100% inhibition. In case of discrepant results MICs were determined by gradient test and compared with the inhibition zones on the same plate. We found a good agreement between the inhibition zone diameters and the MICs for imipenem, metronidazole, moxifloxacin and tigecyclin. The inhibition zone diameters of meropenem also separated clearly the isolates, which can be considered wild-type isolates. In case of amoxicillin/davulanic acid and piperacillin/tazobactam intermediate and susceptible isolates according to the MIC determination, overlap during the zone diameter determination. Isolates with an inhibition zone <23 mm for amoxicillin/clavulanic acid and <25 mm for piperacillin/tazobactam should be retested by a MIC determination method. The 10 mu g clindamycin disc clearly separated the resistant and the susceptible population of B. fragilis group strains. In the case of cefoxitin only resistant population could be separated with an inhibition zone <17 mm, intermediate and susceptible isolates overlap. In conclusion, we suggest that disk diffusion can be an option for susceptibility testing of B. fragilis group isolates for most relevant antibiotics in routine laboratories. (C) 2014 Elsevier Ltd. All rights reserved.
机译:随着脆弱拟杆菌(Bacteroides fragilis)组之间的抗生素耐药性的出现,常规实验室对药敏试验的需求正在增加。本研究的目的是通过将区域直径结果与欧洲范围内抗生素敏感性监测中较早获得的MIC进行比较,以评估在不同的拟杆菌属细菌分离株情况下进行药敏试验的圆盘扩散方法,并提出区域直径断点,与EUCAST MIC断点相关。我们以前通过琼脂稀释法测试了381脆弱型芽孢杆菌临床分离株对阿莫西林/克拉维酸,头孢西丁,克林霉素,亚胺培南,甲硝唑,莫西沙星,哌拉西林/他唑巴坦,替加环素的耐受性。相同的抗生素(包括美罗培南椎间盘)的抑制区域是通过椎间盘在补充有血红素和维生素K1的布鲁氏菌血琼脂上的扩散确定的。将板在厌氧气氛中于37℃温育24小时。在100%抑制下读取区域直径。如果结果不一致,则通过梯度测试确定MIC,并将其与同一平板上的抑制区进行比较。我们发现亚胺培南,甲硝唑,莫西沙星和替加环素的抑菌圈直径与MICs一致。美洛培南的抑制区直径也清楚地分离了分离株,可以将其视为野生型分离株。对于根据MIC测定的阿莫西林/刀豆酸和哌拉西林/他唑巴坦中间体和易感分离株,在区域直径测定期间会重叠。对于阿莫西林/克拉维酸,抑制区<23 mm,对于哌拉西林/他唑巴坦,抑制区<25 mm的分离株应通过MIC测定方法重新测试。 10μg克林霉素圆盘清楚地区分了脆弱脆弱芽孢杆菌群菌株的抗药性和易感种群。在头孢西丁的情况下,只有耐药菌群可以被抑制区<17 mm分开,中间分离株和易感分离株重叠。总而言之,我们建议在常规实验室中,对于大多数相关抗生素,脆性芽孢杆菌组分离物的药敏试验可以选择圆盘扩散法。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号